本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Amryt Pharma

14.70
+0.0000
成交量:- -
成交额:3,506.07万
市值:9.41亿
市盈率:-1,192.12
高:14.70
开:14.70
低:14.70
收:14.70
数据加载中...
2021/05/05

企业合并公告

425 - Prospectuses and communications, business combinations
2021/05/05

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/05/05

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/05/05

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/05/05

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/04/30

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/02/16

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/05

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/01/12

[修订]招股说明书

F-1/A [Amend] - Registration statement for certain foreign private issuers
2021/01/11

SEC问询函

CORRESP [Cover] - Correspondence
2021/01/08

SEC问询函

CORRESP [Cover] - Correspondence
2021/01/08

招股说明书

F-1 - Registration statement for certain foreign private issuers
2020/12/22

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/11/05

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/07/08

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/07/07

SEC问询函

CORRESP [Cover] - Correspondence
2020/07/07

[修订]招股说明书

F-1/A [Amend] - Registration statement for certain foreign private issuers
2020/07/06

[修订]招股说明书

F-1/A [Amend] - Registration statement for certain foreign private issuers